The Temazepam Capsules, cataloged under National Stock Number 6505-01-116-0482, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Mylan Pharmaceuticals Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-116-0482 |
| Primary Part Number | NDC00378-5050-05 |
| Item Name | Temazepam Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Mylan Pharmaceuticals Inc |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 500.000 |
| Active Medicament Medicinal Strength | 30.000 MILLIGRAMS TEMAZEPAM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00378-5050-05 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| NDC00378-5050-05 PRIMARY | Mylan Pharmaceuticals Inc (USA) |
| NDC00781-2202-05 PRIMARY | Sandoz Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC00228-2077-50 | 5/9 Secondary reference Actavis Pharma, Inc. |
NSN 6505-01-116-0482 is a Temazepam Capsules, manufactured by Mylan Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-116-0482 has 3 manufacturer part numbers on file: NDC00378-5050-05 (Mylan Pharmaceuticals Inc), NDC00378-5050-05 (Mylan Pharmaceuticals Inc), NDC00781-2202-05 (Sandoz Inc.).
Key specifications for NDC00378-5050-05: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 500.000; Part Name Assigned by Controlling Agency: TEMAZEPAM CAPSULES 30MG 500S BT; Active Medicament Medicinal Strength: 30.000 MILLIGRAMS TEMAZEPAM ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.